IOSP vs. ASH, BCPC, CC, NGVT, HUN, HWKN, PRM, LOOP, GURE, and OLN
Should you be buying Innospec stock or one of its competitors? The main competitors of Innospec include Ashland (ASH), Balchem (BCPC), Chemours (CC), Ingevity (NGVT), Huntsman (HUN), Hawkins (HWKN), Perimeter Solutions (PRM), Loop Industries (LOOP), Gulf Resources (GURE), and Olin (OLN). These companies are all part of the "chemicals & allied products" industry.
Ashland (NYSE:ASH) and Innospec (NASDAQ:IOSP) are both mid-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability, institutional ownership and community ranking.
94.0% of Ashland shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 0.7% of Ashland shares are held by insiders. Comparatively, 1.4% of Innospec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
In the previous week, Ashland had 21 more articles in the media than Innospec. MarketBeat recorded 42 mentions for Ashland and 21 mentions for Innospec. Ashland's average media sentiment score of 0.87 beat Innospec's score of 0.36 indicating that Innospec is being referred to more favorably in the news media.
Ashland has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than Ashland, indicating that it is currently the more affordable of the two stocks.
Ashland presently has a consensus price target of $106.44, indicating a potential upside of 7.86%. Given Innospec's higher probable upside, equities analysts plainly believe Ashland is more favorable than Innospec.
Ashland has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Innospec has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.
Ashland pays an annual dividend of $1.54 per share and has a dividend yield of 1.6%. Innospec pays an annual dividend of $1.44 per share and has a dividend yield of 1.1%. Ashland pays out 40.8% of its earnings in the form of a dividend. Innospec pays out 24.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ashland has raised its dividend for 14 consecutive years and Innospec has raised its dividend for 9 consecutive years. Ashland is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Ashland received 262 more outperform votes than Innospec when rated by MarketBeat users. Likewise, 68.84% of users gave Ashland an outperform vote while only 65.86% of users gave Innospec an outperform vote.
Ashland has a net margin of 9.09% compared to Ashland's net margin of 7.60%. Ashland's return on equity of 14.22% beat Innospec's return on equity.
Summary
Ashland beats Innospec on 12 of the 20 factors compared between the two stocks.
Get Innospec News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IOSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Innospec Competitors List
Related Companies and Tools
